Arcus Biosciences

RCUS • NYSE • Stock Fundamentals

Arcus Biosciences is a biotechnology company in the healthcare sector trading on NYSE, led by CEO Terry J. Rosen, with a market cap of $2.9B.

Market Cap$2.9B

Employees577.0

CEOTerry J. Rosen

CountryUnited States of America

Healthcare

Biotechnology

Most Recent EarningsMay 5, 2026 · 1 month 9 days agoQ1 2026

Next EarningsAug 5, 2026 · in 2 monthsAfter Market Close · Q2 2026

Financials

Based on Q1 2026 filing

Common questions about Arcus Biosciences

Arcus Biosciences (RCUS) has a market capitalization of $2.9B and trades on NYSE.

Arcus Biosciences has approximately 577 employees.